Cargando…
Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the m...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469469/ https://www.ncbi.nlm.nih.gov/pubmed/31043797 http://dx.doi.org/10.2147/IDR.S190245 |
_version_ | 1783411643787509760 |
---|---|
author | Peterson, Jeffrey C Durkee, Heather Miller, Darlene Maestre-Mesa, Jorge Arboleda, Alejandro Aguilar, Mariela C Relhan, Nidhi Flynn, Harry W Amescua, Guillermo Parel, Jean-Marie Alfonso, Eduardo |
author_facet | Peterson, Jeffrey C Durkee, Heather Miller, Darlene Maestre-Mesa, Jorge Arboleda, Alejandro Aguilar, Mariela C Relhan, Nidhi Flynn, Harry W Amescua, Guillermo Parel, Jean-Marie Alfonso, Eduardo |
author_sort | Peterson, Jeffrey C |
collection | PubMed |
description | PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the molecular and antibiotic resistance profiles of 75 Staphylococcus aureus keratitis isolates collected over an 11-year period (2006–2016). RESULTS: Two major USA clonal complexes (CC), CC5 (n=30, 40%) and CC8 (n=28, 37.3%), accounted for 77.3% of the collected S. aureus isolates. USA100, traditionally healthcare associated (n=18/47, 38.3%), and USA300, traditionally community associated (n=12/47, 25.5%), were the dominant MRSA strains. Four (22.2%) of the USA100 MRSA isolates were recovered from patients with no prior healthcare exposure. Eleven (91.7%) of the USA300 isolates were recovered from patients with documented healthcare risk factors. MSSA isolates were polyclonal (n=13). Ninety-three percent of MSSA infections were of healthcare origin. Thirty-seven of 61 (60.6%) healthcare- and 11 of 14 (78.6%) community-associated strains were resistant to three or more antibiotic classes. Sixty-eight percent (n=51) of isolates harbored three of more resistance determinants (genes). The Panton-Valentine Leucocidin gene was detected in 11 (14.7%) of the study isolates. The majority (72.7%) of the strains were members of the USA300 MRSA clone. CONCLUSION: Clonal complexes CC5 and CC8 were the most frequent clones detected among both the MSSA and the MRSA keratitis isolates. USA100 and USA300 clones were the dominant MRSA genotypes. The USA300 MRSA clone has become a leading cause of healthcare-associated keratitis in South Florida. The USA100 MRSA clone has emerged as an increasing cause of community-associated corneal infections in our outpatient population. This shifting epidemiology coupled with the increasing prevalence of multidrug resistance among both MSSA and MRSA keratitis is a cause of concern. |
format | Online Article Text |
id | pubmed-6469469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64694692019-05-01 Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates Peterson, Jeffrey C Durkee, Heather Miller, Darlene Maestre-Mesa, Jorge Arboleda, Alejandro Aguilar, Mariela C Relhan, Nidhi Flynn, Harry W Amescua, Guillermo Parel, Jean-Marie Alfonso, Eduardo Infect Drug Resist Original Research PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the molecular and antibiotic resistance profiles of 75 Staphylococcus aureus keratitis isolates collected over an 11-year period (2006–2016). RESULTS: Two major USA clonal complexes (CC), CC5 (n=30, 40%) and CC8 (n=28, 37.3%), accounted for 77.3% of the collected S. aureus isolates. USA100, traditionally healthcare associated (n=18/47, 38.3%), and USA300, traditionally community associated (n=12/47, 25.5%), were the dominant MRSA strains. Four (22.2%) of the USA100 MRSA isolates were recovered from patients with no prior healthcare exposure. Eleven (91.7%) of the USA300 isolates were recovered from patients with documented healthcare risk factors. MSSA isolates were polyclonal (n=13). Ninety-three percent of MSSA infections were of healthcare origin. Thirty-seven of 61 (60.6%) healthcare- and 11 of 14 (78.6%) community-associated strains were resistant to three or more antibiotic classes. Sixty-eight percent (n=51) of isolates harbored three of more resistance determinants (genes). The Panton-Valentine Leucocidin gene was detected in 11 (14.7%) of the study isolates. The majority (72.7%) of the strains were members of the USA300 MRSA clone. CONCLUSION: Clonal complexes CC5 and CC8 were the most frequent clones detected among both the MSSA and the MRSA keratitis isolates. USA100 and USA300 clones were the dominant MRSA genotypes. The USA300 MRSA clone has become a leading cause of healthcare-associated keratitis in South Florida. The USA100 MRSA clone has emerged as an increasing cause of community-associated corneal infections in our outpatient population. This shifting epidemiology coupled with the increasing prevalence of multidrug resistance among both MSSA and MRSA keratitis is a cause of concern. Dove Medical Press 2019-04-11 /pmc/articles/PMC6469469/ /pubmed/31043797 http://dx.doi.org/10.2147/IDR.S190245 Text en © 2019 Peterson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Peterson, Jeffrey C Durkee, Heather Miller, Darlene Maestre-Mesa, Jorge Arboleda, Alejandro Aguilar, Mariela C Relhan, Nidhi Flynn, Harry W Amescua, Guillermo Parel, Jean-Marie Alfonso, Eduardo Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title | Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title_full | Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title_fullStr | Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title_full_unstemmed | Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title_short | Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates |
title_sort | molecular epidemiology and resistance profiles among healthcare- and community-associated staphylococcus aureus keratitis isolates |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469469/ https://www.ncbi.nlm.nih.gov/pubmed/31043797 http://dx.doi.org/10.2147/IDR.S190245 |
work_keys_str_mv | AT petersonjeffreyc molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT durkeeheather molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT millerdarlene molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT maestremesajorge molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT arboledaalejandro molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT aguilarmarielac molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT relhannidhi molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT flynnharryw molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT amescuaguillermo molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT pareljeanmarie molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates AT alfonsoeduardo molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates |